Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FGFR2 | P21802 | 1/20 | 0.32 |
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.31 |
| ▸ | KIF11 | P52732 | 1/20 | 0.31 |
| ▸ | LOX | P28300 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28993406 | 0.78 | NOS3 (0.45) | LOXL2LOX | |
| SCHEMBL16450603 | 0.76 | LOXL2 (0.53) | FGFR2LOXL2LOX | |
| SCHEMBL646465 | 0.74 | KDM4E (0.42) | — | |
| SCHEMBL1532137 | 0.74 | CYP2C9 (0.46) | KIF11 | |
| SCHEMBL18997465 | 0.72 | KMT2A (0.48) | — | |
| SCHEMBL21328431 | 0.72 | MGLL (0.44) | LOXL2LOX | |
| SCHEMBL8560257 | 0.71 | RAB9A (0.47) | FGFR2 | |
| SCHEMBL23076530 | 0.71 | LMNA (0.42) | FGFR2LOXL2 | |
| SCHEMBL1977896 | 0.70 | KMT2A (0.42) | — | |
| SCHEMBL803416 | 0.70 | LOX (0.48) | FGFR2LOXL2KIF11LOX |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1830989-A2 | USE OF SUB-MICRON COPPER SALT PARTICLES IN WOOD PRESERVATION | Phibro-Tech, Inc. (US) | 2007-09-12 | — | — | EP | disclosed |
| WO-2006065684-A2 | USE OF SUB-MICRON COPPER SALT PARTICLES IN WOOD PRESERVATION | PHIBRO-TECH, INC. (US) | 2006-06-22 | — | — | WO | disclosed |
| WO-2006042128-A2 | TREATMENT OF WOOD WITH AN INJECTABLE WOOD PRESERVATIVE SLURRY HAVING BIOCIDAL PARTICLES | PHIBRO-TECH, INC. (US) | 2006-04-20 | — | — | WO | disclosed |